Lumea Chooses Tempus to Create AI-Enabled Solutions for Improving Cancer Care
Lumea Inc, a leader in integrated digital pathology solutions, has chosen Tempus, a leader in artificial intelligence and precision medicine, to create AI-enabled solutions that aim to significantly improve the level of care for cancer patients.
Source: azorobotics.com